InvestorsHub Logo

BadSnap

09/17/21 9:56 AM

#90859 RE: billy spec #90858

That would be great. But it ALL depends on the value of those patents. That's the uncertainty. Buyout could also be .20, and that would STILL be a premium. All depends on what those patents are and how valuable that research is to a buyer.

Outlaw141

09/17/21 10:17 AM

#90865 RE: billy spec #90858

Are all the shares being bought by a big pharma player…hostile takeover…No buyout needed…Why pay any more?